Scalable Expansion of Pluripotent Stem Cells

Area of Science:

• Stem cell biology
• Biotechnology
• Cell therapy manufacturing

Background:

• Large-scale expansion of pluripotent stem cells (PSC) is vital for developing cell-based therapeutic products.
• Transitioning from lab-scale to industrial-scale production is a key challenge for human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC).

Purpose of the Study:

• To highlight essential properties for scalable, reproducible, and clinically suitable PSC expansion.
• To describe available platforms and optimization parameters for large-scale PSC expansion in bioreactors.
• To address challenges and considerations for bringing cell-based therapeutics to market.

Main Methods:

• Review of common properties required for cell therapy production.
• Description of available platforms for large-scale PSC expansion.
• Discussion of parameters for optimizing expansion protocols in scalable bioreactors.

Main Results:

• Bioreactor systems facilitate easier optimization and scalability through continuous monitoring and automated control.
• Identified key considerations for scalable PSC expansion including cost-effectiveness, GMP, and regulatory compliance.

Conclusions:

• Optimized, scalable PSC expansion in bioreactors is essential for clinical cell therapy products.
• Addressing manufacturing and regulatory requirements is critical for market success.